1
00:00:02,520 --> 00:00:08,720
Speaker 1: Bloomberg Audio Studios, Podcasts, Radio News, The.

2
00:00:08,720 --> 00:00:12,560
Speaker 2: Stock Movers Report, your roundup of companies making moves in

3
00:00:12,600 --> 00:00:16,800
Speaker 2: the stock market. Harnessing the power of Bloomberg Data.

4
00:00:16,480 --> 00:00:18,159
Speaker 3: Stake a look at some of the stocks on the

5
00:00:18,160 --> 00:00:20,880
Speaker 3: move today. We can do that with avanon her now

6
00:00:21,000 --> 00:00:23,200
Speaker 3: Bloomberg News. She joins us here in study Avalon, What

7
00:00:23,200 --> 00:00:23,720
Speaker 3: are you looking at?

8
00:00:23,920 --> 00:00:25,800
Speaker 1: Yeah, we can go ahead and start off with concentrics

9
00:00:25,800 --> 00:00:29,600
Speaker 1: stutsticker cnxseed down about twenty three percent to hit a

10
00:00:29,640 --> 00:00:32,680
Speaker 1: record low. That's after a firm second quarter forecast was

11
00:00:32,720 --> 00:00:36,680
Speaker 1: weaker than expected. It's adjusted earnings for share guidance missed expectations,

12
00:00:36,720 --> 00:00:39,080
Speaker 1: and also the midpoint of its revenue range also fell

13
00:00:39,120 --> 00:00:41,600
Speaker 1: short of what investors are expecting, which is kind of

14
00:00:41,600 --> 00:00:44,520
Speaker 1: poorly time, considering investors already have a ton of questions

15
00:00:44,560 --> 00:00:47,760
Speaker 1: about what structural threats AI will pose to its business.

16
00:00:48,240 --> 00:00:51,560
Speaker 1: All right, Next up on your list, yes, Jeffreys ticker JEF,

17
00:00:51,680 --> 00:00:54,360
Speaker 1: which is up about three point seven percent. That's after

18
00:00:54,360 --> 00:00:56,680
Speaker 1: The Financial Times reported a little bit earlier today that

19
00:00:56,720 --> 00:01:00,320
Speaker 1: the Japan based bank SMFG is working on plans for

20
00:01:00,440 --> 00:01:03,920
Speaker 1: possible Jeffries buy out. It's kind of interesting timing considering

21
00:01:04,000 --> 00:01:06,360
Speaker 1: Jeffries has been under a lot of pressure this year,

22
00:01:06,680 --> 00:01:09,040
Speaker 1: considering all of the credit risk that the company has

23
00:01:09,080 --> 00:01:11,720
Speaker 1: been caught up in. I'm thinking about like first brands

24
00:01:11,760 --> 00:01:14,440
Speaker 1: market financial solutions. But before this news it was down

25
00:01:14,480 --> 00:01:17,360
Speaker 1: about thirty six percent this year. And Bloomberg Co Intelligence

26
00:01:17,360 --> 00:01:19,320
Speaker 1: is actually out with a note saying that the potential

27
00:01:19,360 --> 00:01:23,600
Speaker 1: takeover by SMFG appears more opportunistic as opposed to imminent,

28
00:01:23,800 --> 00:01:27,000
Speaker 1: as we continue to report that there are no active talks.

29
00:01:27,160 --> 00:01:29,200
Speaker 3: And that bank already owns I looked it up on

30
00:01:29,200 --> 00:01:30,760
Speaker 3: the bloomber turmil about four and a half percent of

31
00:01:30,800 --> 00:01:33,080
Speaker 3: Jeffrey's already, So this might be an opportunity to take

32
00:01:33,120 --> 00:01:36,319
Speaker 3: advantage of some weakness and up that stake here. Jeffries is,

33
00:01:36,360 --> 00:01:38,759
Speaker 3: having competed against them for many years, are very very

34
00:01:38,760 --> 00:01:41,000
Speaker 3: good of what they do. They have their niches and

35
00:01:41,040 --> 00:01:43,080
Speaker 3: they hire and through resources that those niches, and they

36
00:01:43,080 --> 00:01:43,680
Speaker 3: compete well.

37
00:01:44,280 --> 00:01:48,200
Speaker 1: One more, yes, Immunity Bio that's ticker IBRX, thinking about

38
00:01:48,200 --> 00:01:51,000
Speaker 1: twenty two percent for its biggest tumble since twenty twenty four.

39
00:01:51,320 --> 00:01:53,520
Speaker 1: That's after the FDA issued a warning letter to the

40
00:01:53,520 --> 00:01:56,800
Speaker 1: biotech for false and potentially misleading promotion of its bladder

41
00:01:56,840 --> 00:02:00,440
Speaker 1: cancer drug and Ktiva issue was a recent TV add

42
00:02:00,520 --> 00:02:04,920
Speaker 1: and also the firm's billionaire executive chairman Patrick Sounschung's rhetoric

43
00:02:04,960 --> 00:02:07,320
Speaker 1: on the Sean Spicer Show. You said the drug could

44
00:02:07,320 --> 00:02:10,239
Speaker 1: treat all cancers. However, it's currently only approved for a

45
00:02:10,360 --> 00:02:13,520
Speaker 1: very specific kind of bladder cancer. Still worth noting that

46
00:02:13,600 --> 00:02:15,959
Speaker 1: before today the stock was up three hundred and seventy

47
00:02:15,960 --> 00:02:19,000
Speaker 1: five percent this year, so I don't think people are

48
00:02:19,000 --> 00:02:19,880
Speaker 1: gonna be that worried.

49
00:02:20,760 --> 00:02:24,760
Speaker 2: The stock movers report from Bloomberg Radio. Check back with

50
00:02:24,840 --> 00:02:27,399
Speaker 2: us throughout the day for the latest roundup of companies

51
00:02:27,480 --> 00:02:30,600
Speaker 2: making news on Wall Street and for the latest market

52
00:02:30,639 --> 00:02:35,080
Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,

53
00:02:35,200 --> 00:02:38,680
Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with

54
00:02:38,760 --> 00:02:40,240
Speaker 2: the Bloomberg Business app.